Witte AB, Anestl K, Jerremalm E, Ehrsson H, Arnr ES (2005) Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds
5 That pattern of regain is consistent across trials, particularly when people stop these medications suddenly before theyve built the habits needed to maintain their new weight
When hunger is low, cooking feels like less of a priority
These flavonoids work together to support healthy inflammatory responses
Clinical trials: 15-20% weight loss Real world average: ~12% for full-year users Early stoppers (common): only 3.6% weight loss Side effects: 50% experience nausea, 33% experience diarrhea Ask: What percentage of your patients achieve and maintain their weight loss goals? 5
There are also new oral GLP-1 options generating a lot of interest for eligible patients